125 related articles for article (PubMed ID: 12829984)
1. A model to predict severe HCV-related disease following liver transplantation.
Berenguer M; Crippin J; Gish R; Bass N; Bostrom A; Netto G; Alonzo J; Garcia-Kennedy R; Rayón JM; Wright TL
Hepatology; 2003 Jul; 38(1):34-41. PubMed ID: 12829984
[TBL] [Abstract][Full Text] [Related]
2. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
Belli LS; Burroughs AK; Burra P; Alberti AB; Samonakis D; Cammà C; De Carlis L; Minola E; Quaglia A; Zavaglia C; Vangeli M; Patch D; Dhillon A; Cillo U; Guido M; Fagiuoli S; Giacomoni A; Slim OA; Airoldi A; Boninsegna S; Davidson BR; Rolles K; Pinzello G
Liver Transpl; 2007 May; 13(5):733-40. PubMed ID: 17370330
[TBL] [Abstract][Full Text] [Related]
3. Recurrent hepatitis C posttransplant: early preservation injury may predict poor outcome.
Watt KD; Lyden ER; Gulizia JM; McCashland TM
Liver Transpl; 2006 Jan; 12(1):134-9. PubMed ID: 16382465
[TBL] [Abstract][Full Text] [Related]
4. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern?
Berenguer M; Aguilera V; Prieto M; Carrasco D; Rayón M; San Juan F; Landaverde C; Mir J; Berenguer J
Liver Transpl; 2003 Nov; 9(11):1152-8. PubMed ID: 14586875
[TBL] [Abstract][Full Text] [Related]
5. Long-term results and modeling to predict outcomes in recipients with HCV infection: results of the NIDDK liver transplantation database.
Charlton M; Ruppert K; Belle SH; Bass N; Schafer D; Wiesner RH; Detre K; Wei Y; Everhart J
Liver Transpl; 2004 Sep; 10(9):1120-30. PubMed ID: 15350002
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.
Takada Y; Haga H; Ito T; Nabeshima M; Ogawa K; Kasahara M; Oike F; Ueda M; Egawa H; Tanaka K
Transplantation; 2006 Feb; 81(3):350-4. PubMed ID: 16477219
[TBL] [Abstract][Full Text] [Related]
7. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation for HCV-associated liver cirrhosis: predictors of outcomes in a population with significant genotype 3 and 4 distribution.
Zekry A; Whiting P; Crawford DH; Angus PW; Jeffrey GP; Padbury RT; Gane EJ; McCaughan GW;
Liver Transpl; 2003 Apr; 9(4):339-47. PubMed ID: 12682883
[TBL] [Abstract][Full Text] [Related]
9. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection.
Firpi RJ; Abdelmalek MF; Soldevila-Pico C; Cabrera R; Shuster JJ; Theriaque D; Reed AI; Hemming AW; Liu C; Crawford JM; Nelson DR
Liver Transpl; 2004 Oct; 10(10):1240-7. PubMed ID: 15376304
[TBL] [Abstract][Full Text] [Related]
10. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
Yosry A; Esmat G; El-Serafy M; Omar A; Doss W; Said M; Abdel-Bary A; Hosny A; Marawan I; El-Malt O; Kamel RR; Hatata Y; Ghali A; Sabri H; Kamel S; El-Gbaly H; Tanaka K
Transplant Proc; 2008 Jun; 40(5):1481-4. PubMed ID: 18589133
[TBL] [Abstract][Full Text] [Related]
11. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
Rayhill SC; Wu YM; Katz DA; Voigt MD; Labrecque DR; Kirby PA; Mitros FA; Kalil RS; Miller RA; Stolpen AH; Schmidt WN
Transplantation; 2007 Aug; 84(3):331-9. PubMed ID: 17700157
[TBL] [Abstract][Full Text] [Related]
12. Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation.
Botha JF; Thompson E; Gilroy R; Grant WJ; Mukherjee S; Lyden ER; Fox IJ; Sudan DL; Shaw BW; Langnas AN
Liver Int; 2007 Aug; 27(6):758-63. PubMed ID: 17617118
[TBL] [Abstract][Full Text] [Related]
13. Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation.
Chopra KB; Demetris AJ; Blakolmer K; Dvorchik I; Laskus T; Wang LF; Araya VR; Dodson F; Fung JJ; Rakela J; Vargas HE
Transplantation; 2003 Nov; 76(10):1487-91. PubMed ID: 14657691
[TBL] [Abstract][Full Text] [Related]
14. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C.
Machicao VI; Bonatti H; Krishna M; Aqel BA; Lukens FJ; Nguyen JH; Rosser BG; Satyanarayana R; Grewal HP; Hewitt WR; Harnois DM; Crook JE; Steers JL; Dickson RC
Transplantation; 2004 Jan; 77(1):84-92. PubMed ID: 14724440
[TBL] [Abstract][Full Text] [Related]
15. Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression.
Berenguer M; Aguilera V; Prieto M; San Juan F; Rayón JM; Benlloch S; Berenguer J
J Hepatol; 2006 Apr; 44(4):717-22. PubMed ID: 16487616
[TBL] [Abstract][Full Text] [Related]
16. Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index.
Sud A; Hui JM; Farrell GC; Bandara P; Kench JG; Fung C; Lin R; Samarasinghe D; Liddle C; McCaughan GW; George J
Hepatology; 2004 May; 39(5):1239-47. PubMed ID: 15122752
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: a retrospective analysis of 939 liver biopsies in a single center.
Walter T; Dumortier J; Guillaud O; Hervieu V; Scoazec JY; Boillot O
Liver Transpl; 2007 Feb; 13(2):294-301. PubMed ID: 17256784
[TBL] [Abstract][Full Text] [Related]
18. Outcomes after lung transplantation in patients with chronic hepatitis C virus infection.
Sahi H; Zein NN; Mehta AC; Blazey HC; Meyer KH; Budev M
J Heart Lung Transplant; 2007 May; 26(5):466-71. PubMed ID: 17449415
[TBL] [Abstract][Full Text] [Related]
19. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.
Khapra AP; Agarwal K; Fiel MI; Kontorinis N; Hossain S; Emre S; Schiano TD
Liver Transpl; 2006 Oct; 12(10):1496-503. PubMed ID: 16964597
[TBL] [Abstract][Full Text] [Related]
20. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.
Neumann UP; Berg T; Bahra M; Seehofer D; Langrehr JM; Neuhaus R; Radke C; Neuhaus P
J Hepatol; 2004 Nov; 41(5):830-6. PubMed ID: 15519657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
